How Ligand Binds to the Type 1 Insulin-Like Growth Factor Receptor

Nature Communications - United Kingdom
doi 10.1038/s41467-018-03219-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Growth Delay Due to Insulin-Like Growth Factor Type 1 Deficiency

2020English

Type 1 Insulin-Like Growth Factor Receptor Targeted Therapies in Pediatric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2013English

All-Atom Structural Models of the Transmembrane Domains of Insulin Receptor and Type-1 Insulin-Like Growth Factor Receptor

Biophysical Journal
Biophysics
2016English

Disruption of the Insulin-Like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Identification of an Inhibitory Mechanism of Luteolin on the Insulin-Like Growth Factor-1 Ligand-Receptor Interaction

ChemBioChem
Organic ChemistryBiochemistryMolecular MedicineMolecular Biology
2013English

The Three Dimensional Structure of the Type I Insulin-Like Growth Factor Receptor

Molecular Pathology
2001English

Targeting the Insulin Growth Factor Receptor 1

Hematology/Oncology Clinics of North America
OncologyHematology
2012English

C-Terminal SRC Kinase Associates With Ligand-Stimulated Insulin-Like Growth Factor-I Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy